Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients | MicrobiomeTrials← Back to trialsNCT06824454
Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2025-05-15Est. Completion: 2027-05
Enrollment target: 90 participants Locations- Stanford University, Stanford, California, United States
Other microbiome trials you might be interested in
SepsisAcute Kidney InjuryContinuous Renal Replacement Therapy (CRRT)
This multicenter, randomized, open-label, active-controlled, parallel-group trial will evaluate the efficacy and safety …
Multiple LocationsEst. completion Jun 10, 2028
HypophosphatemiaRicketsHypercalciuriaXLHHHRH
Determine the association between duration and dose of chronic conventional therapy with Pi and renal (nephrocalcinosis/…
New Haven, United StatesEst. completion Apr 2028